Yoshiaki Nagatani

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 04, 2025
A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

Yoshiaki Nagatani, Naomi Kiyota, Tomoko Yamazaki

Pageof 1